Summit debuts second-generation digital
While other nuclear medicinevendors play catch up by adding digital to their gamma cameras,digital pioneer Summit Nuclear will display its second-generationall-digital gamma cameras, FX-80 and FX-40. The cameras will make their RSNA debut after being
While other nuclear medicinevendors play catch up by adding digital to their gamma cameras,digital pioneer Summit Nuclear will display its second-generationall-digital gamma cameras, FX-80 and FX-40.
The cameras will make their RSNA debut after being introducedat the Society of Nuclear Medicine meeting earlier this year (SCAN6/15/94). FX-80 is a dual-head system, while FX-40 is a single-headcamera, according to Gary Enos, vice president. Summit, of Twinsburg,OH, expects to begin shipping the FX line next month.
Summit's first-generation cameras, T-22 and 1024-RZ, were developedin cooperation with Hitachi. The FX series, however, has beendesigned and manufactured solely by Summit, Enos said. T-22 and1024-RZ will continue to be offered.
The FX cameras feature slip-ring technology and rectangulardetectors that use the detector head's entire field-of-view forimaging. Summit will showcase its work in 511-KeV imaging forthe dual-head camera, which uses a coincidence counting methodthat allows each detector to decode independently. This improvesimage quality in 511-KeV studies.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
